Development of a radiosensitivity gene signature for patients with soft tissue sarcoma

Adjuvant radiotherapy is an important clinical treatment option for the majority of sarcomas. The motivation of current study is to identify a gene signature and to predict radiosensitive patients who are most likely to benefit from radiotherapy. Using the public available data of soft tissue sarcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Zaixiang, Zeng, Qinghua, Li, Yan, Zhang, Xinyan, Ma, Jinlu, Suto, Mark J., Xu, Bo, Yi, Nengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432346/
https://www.ncbi.nlm.nih.gov/pubmed/28404969
http://dx.doi.org/10.18632/oncotarget.16194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432346/
https://www.ncbi.nlm.nih.gov/pubmed/28404969
http://dx.doi.org/10.18632/oncotarget.16194

Ejemplares similares